GTC Biotherapeutics (fka GTCB)

[y3maxx]

ThomasS wrote

""BTW, do you really believe that $1.19 is justified? I didn't think so. It has little to do with confidence in management by the "Market," imo.""

I completely disagree thomass

investing 101

Its about qualified leadership imo, the CEO & CFO's recent track record include two questionable recent share deals without any plausable explanation to its stakeholders. They forecast there was enough cash on hand to last into /07 before the first July dilution. So much for guidance.

They have not put a single penny of their own skin at these cheap street share prices.

They believe shareholders have no right to question their request to print a 100% increase in new shares.

These CEO and especially the CFO are coming across more as unqualified business leaders and lacking common sense.

jmo